Doron Lipson,
Director
Doron Lipson, Ph.D., has over 10 years of experience in developing genomic applications. He is currently leading a team responsible for developing clinical-grade computational methods for detecting driver alterations in tumors from NGS data at Foundation Medicine. Previously, has worked at Helicos BioSciences and at Agilent, and was a co-founder of ProteOptics, which was acquired by Bio-Rad in 2006. Doron received his Ph.D. and M.S. in Computer Science from Israel Institute of Technology, and his B.S. in Computer Science and Biology from the Hebrew University of Jerusalem. During his career Doron has been widely published in a variety of journals including Nature, Science, Nature Medicine, PNAS and Genome Research and has over 15 accepted and pending patents in the fields of microarrays, sequencing, and surface plasmon resonance.
|
|
|
